[en] Expression of Gal alpha 1-3Gal cell surface residues has been correlated with the metastatic potential of murine tumor cells. We report that Gal alpha 1-3Gal residues are expressed at the cell surface of malignant human cancer cells, including four cell lines and 50% of the malignant breast specimens obtained by aspiration biopsy. In contrast, all benign breast biopsies and normal cells were Gal alpha 1-3Gal negative. Affinity-purified anti-alpha-galactosyl IgG (anti-Gal) antibody, which specifically recognizes Gal alpha 1-3Gal residues, significantly inhibited cell attachment in two in vitro assays thought to indicate tumor cell extravasation of the circulatory system during the metastatic process: attachment to perfused human umbilical vein endothelium, and attachment to isolated laminin. Since anti-Gal antibody is a natural component of all human sera, we propose that it may be part of the natural antitumor defense system in humans.
POSTE G, FIDLER U. The pathogenesis of cancer metastasis. Nature 1980,283:139-146.
FIDLER U, GERSTEM DM, HART LR. The biology of cancer invasion and metastasis. Adv Cancer Res 1978;28:149-250.
LJOTTA LA. Tumor invasion and metastasis: role of the extracellular matrix. Rhoads memorial award lecture. Cancer Res 1986;46:1-7.
DENNIS JW, LAFERTE S, WAGHORNE C, et al. 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987;36;582-585.
YOGEESWARAN G, SALX PL. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 1981;212:1514-1516.
SCHIRRMAKER V, ALTEVOGT P, FOGEL M, et al. Importance of cell surface carbohydrate in cancer cell adhesion, invasion and metastasis. Invasion Metast 1982;2:313-360.
MCCOY JP, GOLDSTEIN II, VARANI J. A review of studies of our laboratory regarding Ella methodology for the study of cell surface carbohydrates from tumors of varying metastatic potential. Tumor Biol 1985;6:99-114.
VARANI J, LOVET EJ, WICHA M, et al. Cell surface a-D-galactopyranosyl end groups: use as markers in the isolation of murine tumor cell lines with different cancer-causing potentials. JNCI 1983;71:1281-1287.
GRIMSTAD IA, VARANI J, MCCOY JP. Contribution of a-D-galactopyranosyl end groups to attachment of highly and low metastatic murine fibrosarcoma cells to various substrates. Exp Cell Res 1984;155:345-358.
GRIMSTAD LA, BOSNES V. Cell surface laminin-like molecules and a-D-galactopyranosyl end groups of cloned strongly and weakly metastatic murine fibrosarcoma cells. Int J Cancer 1987;40:505-510.
GAULI U, RACHMLEWTTZ E, PELEG A, et al. A unique natural human IgG antibody with antigen anti-a-galactosyl specificity. J Exp Med 1984;160:1519-1531.
GALUJ U, MACHER BA, BUEHLER J, et al. Human natural anti-a-galactosyl IgG. IL The specific recognition of a(l-3)-linked galactose residues. J Exp Med 1985;162:573-582.
GALIU U, BUEHLER J, SHOHET SB, et al. The human natural anti-Gal IgG. HL The subtlety of immune tolerance in man as demonstrated by cross reactivity between natural anti-Gal and anti-B antibodies. J Exp Med 1987,165:693-704.
GALIU U, CLARK MR, SHOHET SB, et al. Evolutionary relationship between the natural anti-Gal antibody and the Galal-3Gal epitope in primates. Proc Natl Acad Sci USA 1987,84:1369-1373.
PETERS B, GOLDSTEIN LI. The use of fluorescein-conjugated Bandaraea simplicifolia B4-isolectin as a histochemical reagent for the detection of a-D-galactopyranosyl groups. Exp Cell Res 1979;120:321-339.
GALUJ U, KORKESH A, KAHANE L et al. Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood 1983;61:1258-1264.
GAULI U, FLECHNER L, KNYSZYNSKI A, et al. The natural anti-a-galactosyl IgG on human normal senescent red blood cells. Br J Haematol 1986;62:317-324.
GALIU U, CLARK M, SHOHET SB. Excessive binding of natural anti-a-galactosyl immunoglobulin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest 1986,77:27-33.
MANOURY R. Etablissement et characterisation de trois lignees cellulaires humaines de- rivees de tumeurs metastatiques cdrebrales. C R Acad Sci (Paris) 1977;284:991-998.
CASTRONOVO V, FOIDART JM, LJ VECCHI M, et al. Human anti-alpha-galactosyl IgG reduces the lung colonization by murine MO4 cells. Invasion Metast 1987;7:325-345.
SUNDREHACEN E, BENGTSSON A, BREMER P, et al. A new method for granulocyte labelling with technetium-99m: preliminary results in abscess detection. J Nucl Med 1986;27:551-558.
CASTRONOVO V, PARENT B, FOIDART JM, et al. Ex vivo perfusion of human umbilical veins: a new approach to study the interactions of circulating malignant cells with vascular wall, and their modulations. Invasion Metast. In press.
TIMPL R, ROHDE H, GEHRON-ROBEY P, et al. Laminin, a glycoprotein from basement membranes. J Biol Chem 1979;254:9933-9937.
WEWER UM, LJOTTA LA, JAYE M, et al. Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci USA 1981;83:7137-7141.
KRESS BC, SPIRO RG. Occurrence of a-Dgalactosyl residues on the thyrotropin receptor and othe glycoconjugates of calf thyroid cell surface. Fed Proc 1984;43:1706-1713.
RACE RR, SANGER R. Blood groups in man, 4th ed. Oxford: Blaclcwell Scientific Publications Ltd., 1962:393-404.
HAKKINEM L: A-like blood group antigen in gastric cancer cells of patients in blood groups O or B. J Natl Cancer Inst 1970;44:1183-1190.
CLAUSEN H, HAKOMORI S-I, GRAEM N, et al. Incompatible A antigen expressed in tumors of blood group O individuals: immunochemical, immunohistologic, and enzymatic characterization. J Immunol 1986;136:326-330.
